Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.
Sazonova, I Y
Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator. [electronic resource] - Journal of thrombosis and haemostasis : JTH Aug 2009 - 1321-8 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-7836
10.1111/j.1538-7836.2009.03491.x doi
Animals
Drug Delivery Systems--methods
Fibrin--antagonists & inhibitors
Fibrinolysis--drug effects
Humans
Mice
Mice, Transgenic
Protein Engineering
Streptokinase--genetics
Thrombosis--drug therapy
Tissue Plasminogen Activator--therapeutic use
Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator. [electronic resource] - Journal of thrombosis and haemostasis : JTH Aug 2009 - 1321-8 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-7836
10.1111/j.1538-7836.2009.03491.x doi
Animals
Drug Delivery Systems--methods
Fibrin--antagonists & inhibitors
Fibrinolysis--drug effects
Humans
Mice
Mice, Transgenic
Protein Engineering
Streptokinase--genetics
Thrombosis--drug therapy
Tissue Plasminogen Activator--therapeutic use